Aug 2026
Deep learning-driven discovery and optimization of natural LSD1 inhibitors for the treatment of Alzheimer's disease.
This study provides a generalized DTA tool for early-stage drug development, and identifies S3 as a novel LSD1 inhibitor with potent anti-AD efficacy, by addressing unmet demands for AI-assisted anti-AD lead discovery.
Zhong-Hua Li, Tiancheng Sun, M. Han et al.
· Bioorganic chemistry (Print) · 0 citations